Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by Rigshospitalet, Denmark.
Recruitment status was Recruiting
Information provided by:
First received: January 5, 2006
Last updated: May 21, 2008
Last verified: May 2008
Hypothesis is that surgery is of benefit in locally advanced NSCLC with N2 disease.
Patients are randomised to surgery or not.
Non-Small Cell Lung Cancer
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
||Scandinavian Neoadjuvant Phase III Study of Induction Chemotherapy Followed by Irradiation Alone or Surgery Plus Irradiation in NSCLC Stage IIIA/N2 (T1N2, T2N2, T3/N2).
Primary Outcome Measures:
Secondary Outcome Measures:
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
Patients are after staging randomised to neoadj. chemotherapy followed by surgery followed by irradiation or to chemotherapy followed by irradiation.
Endpoint is survival.
|Ages Eligible for Study:
||18 Years to 75 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- Histologically verified NSCLC
- Stage IIIA/N2
- age 18-75
- Lung function test allowing surgery
- Mediastinoscopy performed
- Prior chemotherapy
- Prior irradiation
Please refer to this study by its ClinicalTrials.gov identifier: NCT00273494
|Dept. Oncology, Rigshospitalet
|Copenhagen, Denmark, 2100 |
|Contact: Jens B. Sorensen, MD 35454372 firstname.lastname@example.org |
|Contact: Jens B. Sorensen, MD 35454372 ext email@example.com |
|Principal Investigator: Jens B. Sorensen, MD |
||Jens B. Sorensen, MD
No publications provided
History of Changes
|Other Study ID Numbers:
||Surgery in NSCLC stage IIIA/N2
|Study First Received:
||January 5, 2006
||May 21, 2008
||Denmark: National Board of Health
Keywords provided by Rigshospitalet, Denmark:
Non-small cell lung cancer
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on March 06, 2014
Carcinoma, Non-Small-Cell Lung
Respiratory Tract Neoplasms
Neoplasms by Site
Respiratory Tract Diseases